Refreshing results…
Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase
UploadRisk of Adverse Events and Delirium after COVID-19 Vaccination in Patients Living with Dementia
UploadEffectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19
UploadMissing publications? Search for publications with a matching author name.